Use of pegfilgrastim support on day 9 to maintain relative dose intensity of chemotherapy in breast cancer patients receiving a day 1 and 8 CMF regimen.

Source:http://linkedlifedata.com/resource/pubmed/id/20045791

Download in:

View as

General Info

PMID
20045791